Karo Pharma AB (XSTO:KARO) - Share price


Stock Report

Karo Pharma AB KARO

Last Price
SEK52.00

Day Change
1.80|3.59%

As of 01/07/2022
17:29:35 CEST | SEK
Minimum 15 Minutes Delay.

Last Close50.20
Day Range50.00 - 52.00
Mkt Cap14.21Bil
52-Wk Range49.25 - 64.64
Yield %-
ISINSE0007464888
Volume28,261
P/E204.08
P/S3.96
P/CF22.03

Share Price

Financials
201920202021
More ...
Income Statement
Revenue1,901.202,882.872,961.35
Operating Income202.44250.08199.18
Net Income8.8982.05-17.45
Basic EPS0.050.37-0.08
Avg. Diluted Shares Outstanding175224226
Balance Sheet
Current Assets1,175.061,731.051,491.29
Non Current Assets9,723.4710,786.4511,102.13
Total Assets10,898.5312,517.5012,593.42
Current Liabilities3,536.125,221.47586.34
Total Liabilities---
Total Equity5,640.275,636.055,811.42
Cash Flow
Operating Cash Flow106.84329.22532.60
Capital Expenditure-34.55-1,706.68-900.89
Free Cash Flow72.30-1,377.45-368.29

In millions, except "Basic EPS". Currency is SEK.

Company Profile

Karo Pharma AB is a healthcare corporation. It is primarily engaged in the business activity of developing and marketing products to pharmacies and directly to the healthcare sector. The trademarks of the firm are Ibux, Paracet, Dosett, Allevo, and Swereco. It operates in the segment of research and development for drug discovery. The company carries its business operations in Sweden and internationally, of which the majority of the revenue is generated from Sweden and Norway.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Stock Style

Small-Blend

Fiscal Year Ends

December

Employees

225
Key Stats
More ...
Price/Earning TTM-631.03
Price/Book2.36
Price/Sales TTM3.88
Rev Growth (3 year avg)22.39
EPS Growth (3 year avg)-
Operating Margin % TTM6.73
Net Margin % TTM-0.59
ROE TTM-0.30
Debt/Equity0.97
Dividends
PreviousLatest
More ...
Declared Date31/03/1706/04/18
Ex-Div12/05/1704/05/18
Paid18/05/1711/05/18
Amnt0.240.27
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2022 Morningstar. All rights reserved.